{"transactions":[{"id":2428039,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-24T21:18:57.000Z","date":"2022-01-20","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments from January 18, 2022."}],"balance_after":8500,"derivative":{"exercise_price":53.01,"expiration_date":"2025-01-18","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001250853-22-000028","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085322000028/primary_doc.xml","form_type":"4"}},{"id":2462403,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to Puchase common stock","published_at":"2021-12-21T18:26:48.000Z","date":"2019-03-21","kind":"purchase","acquired":true,"shares":3598,"price":6.67,"value":23998.66,"ownership":{"direct":true},"balance_after":3598,"derivative":{"exercise_price":6.67,"exercise_date":"2019-03-21","expiration_date":"2024-12-31","underlying":"Common Stock","underlying_shares":3598},"source":{"system":"sec-edgar","filing":"0001486189-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618921000014/primary_doc.xml","form_type":"4"}},{"id":2462402,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2021-12-21T18:26:48.000Z","date":"2020-08-05","kind":"purchase","acquired":true,"shares":85120,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029\n45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027\n30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024"},{"field":"date","element":"transactionDate","label":"F2","text":"10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029\n45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027\n30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029\n45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027\n30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029\n45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027\n30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029\n45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027\n30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024"}],"balance_after":85120,"derivative":{"underlying":"Common Stock","underlying_shares":85120},"source":{"system":"sec-edgar","filing":"0001486189-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618921000014/primary_doc.xml","form_type":"4"}},{"id":2462401,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T18:26:48.000Z","date":"2021-01-28","kind":"other","acquired":true,"shares":268263,"price":2.04,"value":547256.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquired as per Merger Transaction exchange"}],"balance_after":277259,"source":{"system":"sec-edgar","filing":"0001486189-21-000014","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618921000014/primary_doc.xml","form_type":"4"}},{"id":2981798,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-11-14T01:42:42.000Z","date":"2020-11-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal quarterly installments from the option grant date."}],"balance_after":20000,"derivative":{"exercise_price":18.2,"expiration_date":"2025-11-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001250853-20-000106","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000125085320000106/primary_doc.xml","form_type":"4"}},{"id":3108932,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-06-16T13:19:54.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":88718,"derivative":{"exercise_price":1.5,"exercise_date":"2020-05-11","expiration_date":"2027-05-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001486189-20-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618920000004/primary_doc.xml","form_type":"4"}},{"id":3139541,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-21T19:44:11.000Z","date":"2020-05-06","kind":"disposition_to_issuer","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options were granted on September 14, 2016, and vested and became exercisable in twelve equal monthly installments commencing on October 14, 2016."}],"balance_after":36909,"derivative":{"exercise_price":5,"expiration_date":"2026-09-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-064720","document":"tm2020664d1_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465920064720/tm2020664d1_form4.xml","form_type":"4"}},{"id":3139540,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T19:44:11.000Z","date":"2020-05-06","kind":"exercise","acquired":true,"shares":20000,"price":5,"value":100000.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001104659-20-064720","document":"tm2020664d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465920064720/tm2020664d1_form4.xml","form_type":"4"}},{"id":3167375,"issuer":{"id":4803,"kind":"organization","name":"Nutex Health Inc.","symbol":"NUTX"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-04-29T19:10:58.000Z","date":"2020-01-27","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter."}],"balance_after":58718,"derivative":{"exercise_price":1.5,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001486189-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479681/000148618920000002/primary_doc.xml","form_type":"4"}},{"id":3177332,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-14T20:21:32.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":3409,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."},{"field":"shares","element":"transactionShares","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024."}],"balance_after":56909,"derivative":{"exercise_price":18.41,"expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":3409},"source":{"system":"sec-edgar","filing":"0001104659-20-046377","document":"tm2015807d2_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465920046377/tm2015807d2_4a.xml","form_type":"4/A","original_submission_date":"2020-02-21"}},{"id":3257317,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-21T20:10:02.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":3550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the \"Company\"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."},{"field":"kind","element":"transactionCoding","label":"F1","text":"In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the \"Company\"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the \"Company\"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the \"Company\"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the \"Company\"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."}],"balance_after":57050,"derivative":{"exercise_price":17.57,"expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":3550},"source":{"system":"sec-edgar","filing":"0001104659-20-023830","document":"tm209648-5_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465920023830/tm209648-5_4.xml","form_type":"4"}},{"id":3257315,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-21T20:05:40.000Z","date":"2020-02-05","kind":"other","acquired":false,"shares":2048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\") under the Company's 2015 Equity Incentive Plan."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\") under the Company's 2015 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\") under the Company's 2015 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the \"Company\") under the Company's 2015 Equity Incentive Plan."}],"balance_after":53500,"derivative":{"exercise_price":17.57,"expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":2048},"source":{"system":"sec-edgar","filing":"0001104659-20-023827","document":"tm209648d4_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465920023827/tm209648d4_4a.xml","form_type":"4/A","original_submission_date":"2019-12-26"}},{"id":3331578,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-12-26T11:07:43.000Z","date":"2019-11-25","kind":"grant","acquired":true,"shares":2048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020."}],"balance_after":55548,"derivative":{"exercise_price":17.57,"exercise_date":"2020-02-25","expiration_date":"2024-11-25","underlying":"Common Stock","underlying_shares":2048},"source":{"system":"sec-edgar","filing":"0001104659-19-075849","document":"tm1927354d4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919075849/tm1927354d4_4.xml","form_type":"4"}},{"id":3364629,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-11-20T19:20:38.000Z","date":"2019-10-11","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020."}],"balance_after":53500,"derivative":{"exercise_price":15.35,"exercise_date":"2020-01-11","expiration_date":"2024-10-11","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-19-065777","document":"tm1923454d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000110465919065777/tm1923454d6_4.xml","form_type":"4"}},{"id":3491730,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T23:14:03.000Z","date":"2019-06-11","kind":"purchase","acquired":true,"shares":10000,"price":14.13,"value":141300.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001553350-19-000639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000639/ownership.xml","form_type":"4"}},{"id":3561865,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-04-05T23:39:42.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4/A is being filed to correct the Date Exercisable, Expiration Date and vesting schedule for the stock options previously reported in the Form 4 filed by the Reporting Person on January 15, 2019 as follows: (i) the Date Exercisable is April 11, 2019; (ii) the Expiration Date is January 11, 2024; and (iii) the stock options vest in 4 installments on April 11, 2019; July 11, 2019; October 11, 2019; and January 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4/A is being filed to correct the Date Exercisable, Expiration Date and vesting schedule for the stock options previously reported in the Form 4 filed by the Reporting Person on January 15, 2019 as follows: (i) the Date Exercisable is April 11, 2019; (ii) the Expiration Date is January 11, 2024; and (iii) the stock options vest in 4 installments on April 11, 2019; July 11, 2019; October 11, 2019; and January 11, 2020."}],"balance_after":7500,"derivative":{"exercise_price":18.11,"exercise_date":"2019-04-11","expiration_date":"2024-01-11","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001553350-19-000339","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000155335019000339/ownership.xml","form_type":"4/A","original_submission_date":"2019-01-15"}},{"id":3695735,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-01-16T00:43:42.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer granted these options to Mr. Fawcett in consideration for his service as a director.  They vest in 4 installments over one year quarterly on March 31, June 30, September 30 and December 31."}],"balance_after":7500,"derivative":{"exercise_price":18.11,"exercise_date":"2019-03-31","expiration_date":"2023-12-31","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001567619-19-001175","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000156761919001175/doc1.xml","form_type":"4"}},{"id":4415056,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-01T19:12:44.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016."}],"balance_after":20000,"derivative":{"exercise_price":5,"exercise_date":"2016-10-16","expiration_date":"2026-09-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001498865-17-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000149886517000004/primary_doc.xml","form_type":"4"}},{"id":4601777,"issuer":{"id":4538,"kind":"organization","name":"Astrana Health, Inc.","symbol":"ASTH"},"owners":[{"id":78375,"kind":"person","name":"Fawcett Mark","position":1,"cik":"0001664134","reported_name":"Fawcett Mark","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-09-16T20:59:36.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted.  The Issuer's shareholders approved the plan on September 14, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016."}],"balance_after":15000,"derivative":{"exercise_price":5.79,"exercise_date":"2016-09-14","expiration_date":"2026-02-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001498865-16-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1083446/000149886516000009/primary_doc.xml","form_type":"4"}}]}